skills/capital-markets-issuance/references/sector-nuances.md

# Sector and situation nuances

Use this reference to tailor issuance advice by issuer type. Always prioritize issuer-specific facts over generic sector rules.

## Technology and software
Focus on arr, growth, retention, rule-of-40, sales efficiency, fcf path, valuation multiples, volatility, and crossover investor appetite.

Judgment:
- Converts can be attractive when volatility is high and cash coupon matters.
- Common equity works when proceeds fund credible growth or m&a, not vague spending.
- Investors punish raises if growth is decelerating and use of proceeds is unclear.

## Biotech and healthcare
Focus on runway, clinical catalysts, regulatory milestones, specialist investors, and atm/pipe/follow-on windows.

Judgment:
- Raise after positive data when possible, before runway becomes short.
- Specialist investor support can matter more than broad market tone.
- Proceeds should fund named trials or milestones.

## Energy and natural resources
Focus on commodity prices, hedging, reserve base, capex, decline curves, asset coverage, rbl capacity, and environmental liabilities.

Judgment:
- Debt capacity depends on downside commodity assumptions.
- Equity issuance after commodity rallies can work if framed around discipline, not production growth at any cost.

## Industrials
Focus on cyclicality, backlog, working capital, capex, margin durability, end-market exposure, and m&a funding.

Judgment:
- Issuing before a downturn can be prudent but may signal concern.
- Credit investors care about downside ebitda and cash conversion.

## Consumer and retail
Focus on same-store sales, brand strength, inventory, margin pressure, leases, seasonality, and secured debt capacity.

Judgment:
- Investor appetite can change quickly after peer misses or consumer data.
- "Flexibility" proceeds language may read as distress if trends are weakening.

## Financial institutions
Focus on regulatory capital, cet1/tier 1/leverage ratios, asset quality, deposits, liquidity coverage, preferred/subordinated debt, and regulator/rating treatment.

Judgment:
- Instrument choice is often determined by regulatory and rating capital treatment.
- Investor base is specialized and highly sensitive to asset quality.

## Insurance
Focus on capital adequacy, reserve risk, investment portfolio, catastrophe exposure, reinsurance, hybrid capital, and ratings.

Judgment:
- Rating agency treatment can dominate headline coupon.
- Reserve uncertainty widens investor return requirements.

## Utilities and infrastructure
Focus on rate base growth, regulatory construct, capex plan, ratings, dividend policy, long-dated debt, hybrids, equity forwards, and atms.

Judgment:
- Issuance usually supports a multi-year financing plan.
- Equity/hybrid issuance can be acceptable if it preserves ratings and funds regulated growth.

## REITs
Focus on nav, affo, dividend yield, leverage, cap rates, asset quality, secured/unsecured debt, preferreds, atms, and ratings.

Judgment:
- Equity below nav is controversial unless balance-sheet repair is urgent.
- Affo dilution, leverage, and asset quality must be explicit.

## Sponsor-backed issuers
Focus on sponsor objective, hold period, dividend recap optics, leverage, ebitda quality, fcf conversion, lender appetite, private credit vs syndicated market, and exit timeline.

Judgment:
- Dividend recaps require strong credit quality and supportive technicals.
- Sponsor monetization needs retained ownership/lockup discipline.
- Private credit may be preferable when certainty and confidentiality outweigh cost.

## Stressed or distressed issuers
Focus on liquidity runway, debt maturities, covenant breaches, creditor classes, collateral, exchange offers, rescue financing, and restructuring alternatives.

Judgment:
- Traditional issuance advice may be secondary to recovery analysis and creditor dynamics.
- If value breaks or coercive exchange mechanics matter, use distressed recovery analysis.